FLVCR2 and acute myeloid leukemia: For instance, FLVCR2 has been proposed as a prognostic biomarker for acute myeloid leukemia due to its implication in the modulation of the tumor microenvironment in acute myeloid leukemia patients, specifically in terms of immune infiltration degree and cancer cell proliferation rate (143).